In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Wendy Chen comments on research that shows supplements can interfere with cancer drugs, but patients often forget to tell their doctors they're taking them.

Tags: PatientSafety

  • Dr. Eric Winer comments on the efficacy of gene tests for breast cancer patients.

Tags: BreastCancer

  • Dana-Farber has 1,500 pieces of art on its main campus in Boston’s Longwood Medical Area and its satellite sites to help reduce anxiety for patients and their families.

Tags: PatientSupport

  • Dr. Eliezer Van Allen led a study showing why some of the newest cancer therapies don’t work on everyone.

Tags: DrugResistance, Immunotherapy

  • A study led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center showed a high-fat diet may increase an individual’s risk for colon cancer.

Tags: ColonCancer, Nutrition

  • A study led by Dr. Christopher Lathan shows that cancer patients with limited finances are more likely to have increased symptoms and poorer quality of life.

Tags: ColonCancer, LungCancer

  • Dr. Richard Stone talks about a patient who benefited from Profile, Dana-Farber's precision medicine program.  Dr. Barrett Rollins and Dr. Matthew Meyerson also comment.

  • Dr. Laurie H. Glimcher is picked as next Chief Executive Officer of Dana-Farber Cancer Institute.

Tags: Appointments

  • Dana-Farber Cancer Institute has appointed Dr. Laurie Glimcher as its new CEO, the first female CEO in the organization’s 69-year history.

Tags: Appointments

  • Dr. Levi Garraway commented on a promising cancer drug that researchers can use in knocking out cancer cells.

Tags: TargetedTherapy

Showing 21-30 of 660 items